NeurMedix, Inc., is a clinical-stage biotechnology company that engages in development of therapeutic products for the treatment of neurological diseases.
No articles found.
CytoDyn is a publicly traded late stage biotechnology company developing innovativ...
CytoDyn is a publicly traded late stage biotech...
Join the National Investor Network and get the latest information with your interests in mind.